Stay updated on Medicenna Therapeutics Press Releases

Sign up to get notified when there's something new on the Medicenna Therapeutics Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Medicenna Therapeutics Press Releases page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Added a June 26, 2026 News Release titled 'Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights,' indicating new financial results are now published on the page. Removed the May 13, 2026 News Release 'Medicenna Announces the Launch of a Marketed Public Offering of Securities,' updating the feed to reflect that the offering announcement is no longer listed.
    Difference
    3%
    Check dated 2026-06-26T23:47:20.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    Adds a June 11, 2026 item noting Medicenna's strengthened patent estate across IL-2, IL-4 and IL-13 platforms. Removes the May 12, 2026 item announcing the first patient dosed in the NEO-CYT study for MDNA11 in neoadjuvant melanoma.
    Difference
    3%
    Check dated 2026-06-12T14:15:13.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    A June 3, 2026 news release about MDNA11 in earlier-line melanoma is added; the April 30, 2026 NEOCYT ASCO release is removed.
    Difference
    3%
    Check dated 2026-06-05T09:11:09.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Two new news items were added to the News Releases page: May 28, 2026, announcing the closing of a public offering of units to raise CDN$4.44 million. May 22, 2026, announcing the filing of a prospectus supplement and investment term sheet.
    Difference
    4%
    Check dated 2026-05-29T07:39:30.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A new press release dated May 19, 2026 announcing the finalization of the terms of Medicenna's public offering of securities was added to the News Releases page. The April 9, 2026 entry announcing Dr. Nageatte Ibrahim as Chief Medical Officer was removed.
    Difference
    3%
    Check dated 2026-05-22T09:41:33.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Two new News Releases were added for May 13, 2026 and May 12, 2026, announcing a marketed public offering and the first patient dosed in the NEO-CYT study of MDNA11 in Neoadjuvant Melanoma. Two older releases from February and March 2026 were removed, updating the page to reflect current corporate actions and trial milestones.
    Difference
    3%
    Check dated 2026-05-15T05:19:15.000Z thumbnail image

Stay in the know with updates to Medicenna Therapeutics Press Releases

Enter your email address, and we'll notify you when there's something new on the Medicenna Therapeutics Press Releases page.